Rapport Therapeutics, Inc. Common Stock
RAPPNASDAQHealthcare● Active
$38.11
+$1.43(+3.90%)
Market Cap$1.4B
P/E Ratio—
52W High$42.269
52W Low$10.505
Rapport Therapeutics, Inc. Common Stock（RAPP）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RAPP · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Assets | ||||
| Cash & ST Investments | $0.49B | $0.31B | $0.15B | $0.03B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.50B | $0.31B | $0.15B | $0.03B |
| PP&E Net | $0.01B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.51B | $0.31B | $0.16B | $0.03B |
| Liabilities | ||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.02B | $0.01B | $0.01B | $0.00B |
| Long-Term Debt | $0.01B | $0.00B | $0.00B | $0.01B |
| Total Liabilities | $0.03B | $0.01B | $0.18B | $0.01B |
| Stockholders Equity | ||||
| Retained Earnings | ($0.24B) | ($0.12B) | ($0.05B) | ($0.01B) |
| Total Stockholders Equity | $0.48B | $0.31B | ($0.03B) | $0.02B |
| Total Liab & Equity(computed) | $0.51B | $0.31B | $0.16B | $0.03B |
| Debt Summary | ||||
| Total Debt | $0.01B | $0.00B | $0.00B | $0.01B |
| Net Debt | ($0.04B) | ($0.06B) | ($0.07B) | ($0.02B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Rapport Therapeutics, Inc. Common Stock
关于Rapport Therapeutics, Inc. Common Stock（RAPP）资产负债表
Rapport Therapeutics, Inc. Common Stock总资产$0.51B，现金及短期投资$0.49B，总负债$0.03B，总债务$0.01B，股东权益$0.48B。
常见问题
RAPP · 4 问Rapport Therapeutics, Inc. Common Stock总债务$0.01B，净债务($0.04B)。
RAPP total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10